DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 03 · Volume 130 · March 2022 DOI: 10.1055/s-012-53084

Article

  • 145
  • 156
  • 165
    Vainieri, Erika; Ahluwalia, Raju; Slim, Hani; Walton, Daina; Manu, Chris; Taori, Surabhi; Wilkins, Jason; Huang, Dean Y.; Edmonds, Mike; Rashid, Hisham; Kavarthapu, Venu; Vas, Prashanth R J:

    Outcomes after Emergency Admission with a Diabetic Foot Attack Indicate a High Rate of Healing and Limb Salvage But Increased Mortality: 18-Month Follow-up Study

  • 172
    Labenz, Christian; Kostev, Karel; Alqahtani, Saleh A.; Galle, Peter R.; Schattenberg, Jörn M.:

    Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus

  • Review

  • 178
    Müller-Wieland, Dirk; Marx, Nikolaus; Dreher, Michael; Fritzen, Katharina; Schnell, Oliver:

    COVID-19 and Cardiovascular Comorbidities

  • Mini-Review

  • 190
  • Commentary

  • 198
    Papachristou, Stella; Penlioglou, Theano; Stoian, Anca Pantea; Papanas, Nikolaos:

    COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?

  • 200
    Fritsche, Andreas; Heni, Martin; Peter, Andreas; Gallwitz, Baptist; Kellerer, Monika; Birkenfeld, Andreas L.; Häring, Hans-Ulrich; Wagner, Robert:

    Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications

  • Letter to the Editor

  • 205
    Petrakis, Vasileios; Panagopoulos, Periklis; Papazoglou, Dimitrios; Papanas, Nikolaos:

    Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia